54
Participants
Start Date
May 1, 2025
Primary Completion Date
February 9, 2027
Study Completion Date
June 22, 2027
AZD5492
IMP: subcutaneous.
WITHDRAWN
Research Site, Leiden
RECRUITING
Research Site, Toulouse
NOT_YET_RECRUITING
Research Site, Bordeaux
NOT_YET_RECRUITING
Research Site, Montpellier
RECRUITING
Research Site, Anniston
NOT_YET_RECRUITING
Research Site, Magdeburg
RECRUITING
Research Site, Seville
RECRUITING
Research Site, Valladolid
NOT_YET_RECRUITING
Research Site, Cologne
NOT_YET_RECRUITING
Research Site, Nancy
NOT_YET_RECRUITING
Research Site, Strasbourg
NOT_YET_RECRUITING
Research Site, Paris
NOT_YET_RECRUITING
Research Site, Erlangen
NOT_YET_RECRUITING
Research Site, Beijing
NOT_YET_RECRUITING
Research Site, Shanghai
NOT_YET_RECRUITING
Research Site, Wuhan
NOT_YET_RECRUITING
Research Site, Hamilton
NOT_YET_RECRUITING
Research Site, Sherbrooke
NOT_YET_RECRUITING
Research Site, Bunkyō City
NOT_YET_RECRUITING
Research Site, Kita-gun
NOT_YET_RECRUITING
Research Site, Kitakyushu-shi
NOT_YET_RECRUITING
Research Site, Kyoto
NOT_YET_RECRUITING
Research Site, Nagasaki
NOT_YET_RECRUITING
Research Site, Amsterdam
RECRUITING
Research Site, Mérida
RECRUITING
Research Site, Glasgow
RECRUITING
Research Site, London
RECRUITING
Research Site, London
RECRUITING
Research Site, Southampton
Lead Sponsor
Collaborators (1)
Fortrea
INDUSTRY
AstraZeneca
INDUSTRY